Osteogenic Sarcoma and Dedifferentiated Chondrosarcoma

  • David Y. Johnson
  • Shilpi Wadhwa
  • Frank E. JohnsonEmail author
Part of the Current Clinical Oncology book series (CCO)


Data concerning estimated new cases and deaths worldwide in 2002 for osteogenic sarcoma and dedifferentiated chondrosarcoma were not available through the International Agency for Research on Cancer (IARC), a component of the World Health Organization (WHO) [1].


Osteogenic sarcoma Dedifferentiated chondrosarcoma WHO ASC Surveillance 


  1. 1.
    Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents, Vol. VIII, International Agency for Research on Cancer, 2002. (IARC Scientific Publication 155). Lyon, France: IARC Press; 2002. ISBN 92-832-2155-9.Google Scholar
  2. 2.
    Jemal A, Seigel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66.PubMedCrossRefGoogle Scholar
  3. 3.
    Schottenfeld D, Fraumeni JG. Cancer epidemiology and prevention. 3rd ed. New York, NY: Oxford University Press; 2006. ISBN 13:978-0-19-514961-6.CrossRefGoogle Scholar
  4. 4.
    DeVita VT, Hellman S, Rosenberg SA. Cancer. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005. ISBN 0-781-74450-4.Google Scholar
  5. 5.
    Feig BW, Berger DH, Fuhrman GM. The M.D. Anderson surgical oncology handbook. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006. paperback. ISBN 0-7817-5643-X.Google Scholar

Copyright information

© Humana Press 2013

Authors and Affiliations

  • David Y. Johnson
    • 1
  • Shilpi Wadhwa
    • 1
  • Frank E. Johnson
    • 2
    Email author
  1. 1.Department of Internal MedicineSaint Louis University Medical CenterSaint LouisUSA
  2. 2.Saint Louis University Medical Center and Saint Louis Veterans Affairs Medical CenterSaint LouisUSA

Personalised recommendations